(LIN) Linde Ordinary Shares - Overview

Sector: Basic Materials | Industry: Specialty Chemicals | Exchange: NASDAQ (USA) | Market Cap: 233.999m USD | Total Return: 11.7% in 12m

Atmospheric Gases, Process Gases, Industrial Plants
Total Rating 54
Safety 56
Buy Signal 0.33
Specialty Chemicals
Industry Rotation: -3.4
Market Cap: 234B
Avg Turnover: 984M
Risk 3d forecast
Volatility16.3%
VaR 5th Pctl2.88%
VaR vs Median7.02%
Reward TTM
Sharpe Ratio0.49
Rel. Str. IBD51.2
Rel. Str. Peer Group41.5
Character TTM
Beta0.308
Beta Downside0.359
Hurst Exponent0.415
Drawdowns 3y
Max DD19.18%
CAGR/Max DD0.74
CAGR/Mean DD3.06
EPS (Earnings per Share) EPS (Earnings per Share) of LIN over the last years for every Quarter: "2021-03": 2.49, "2021-06": 2.7, "2021-09": 2.73, "2021-12": 2.77, "2022-03": 2.93, "2022-06": 3.1, "2022-09": 3.1, "2022-12": 3.16, "2023-03": 3.42, "2023-06": 3.57, "2023-09": 3.63, "2023-12": 3.59, "2024-03": 3.75, "2024-06": 3.85, "2024-09": 3.94, "2024-12": 3.97, "2025-03": 3.95, "2025-06": 4.09, "2025-09": 4.21, "2025-12": 4.2, "2026-03": 4.33,
EPS CAGR: 9.32%
EPS Trend: 96.8%
Last SUE: 0.10
Qual. Beats: 0
Revenue Revenue of LIN over the last years for every Quarter: 2021-03: 7243, 2021-06: 7584, 2021-09: 7668, 2021-12: 8298, 2022-03: 8211, 2022-06: 8457, 2022-09: 8797, 2022-12: 7899, 2023-03: 8193, 2023-06: 8204, 2023-09: 8155, 2023-12: 8302, 2024-03: 8100, 2024-06: 8267, 2024-09: 8356, 2024-12: 8282, 2025-03: 8112, 2025-06: 8495, 2025-09: 8615, 2025-12: 8764, 2026-03: 8781,
Rev. CAGR: 1.01%
Rev. Trend: 40.2%
Last SUE: 1.18
Qual. Beats: 1

Warnings

No concerns identified

Tailwinds

Confidence

Description: LIN Linde Ordinary Shares

Linde plc is a global leader in the industrial gases sector, producing and distributing atmospheric gases such as oxygen and nitrogen alongside specialty process gases like hydrogen and helium. The company operates a dual-business model that combines gas supply with a proprietary engineering division focused on designing and constructing large-scale chemical and gas processing plants. This integrated approach allows Linde to serve diverse end-markets, including healthcare, electronics, and energy production, across major economies in the Americas, Europe, and Asia-Pacific.

The industrial gas industry is characterized by high barriers to entry due to the capital-intensive nature of air separation units and the logistical complexity of gas distribution. Linde typically utilizes long-term, take-or-pay contracts for on-site supply, which provides a high degree of revenue stability and integrates the company directly into the supply chains of its industrial customers. For a deeper look at company valuation metrics, consider reviewing the latest data on ValueRay.

Headlines to Watch Out For
  • Expansion of global clean hydrogen infrastructure drives long-term capital expenditure growth
  • Resilience in long-term take-or-pay contracts stabilizes cash flow during macro volatility
  • Semiconductor manufacturing expansion in Asia and US boosts high-margin electronic gas demand
  • Energy price fluctuations impact production costs and industrial customer manufacturing output
  • Strategic pricing power in global industrial gas markets offsets persistent inflationary pressures
Piotroski VR‑10 (Strict) 7.5
Net Income: 7.12b TTM > 0 and > 6% of Revenue
FCF/TA: 0.06 > 0.02 and ΔFCF/TA -0.03 > 1.0
NWC/Revenue: -7.62% < 20% (prev -2.69%; Δ -4.93% < -1%)
CFO/TA 0.12 > 3% & CFO 10.43b > Net Income 7.12b
Net Debt (20.72b) to EBITDA (12.31b): 1.68 < 3
Current Ratio: 0.83 > 1.5 & < 3
Outstanding Shares: last quarter (466.3m) vs 12m ago -2.09% < -2%
Gross Margin: 45.99% > 18% (prev 0.37%; Δ 4.56k% > 0.5%)
Asset Turnover: 41.01% > 50% (prev 39.92%; Δ 1.09% > 0%)
Interest Coverage Ratio: 25.42 > 6 (EBITDA TTM 12.31b / Interest Expense TTM 274.0m)
Altman Z'' 1.28
A: -0.03 (Total Current Assets 12.75b - Total Current Liabilities 15.39b) / Total Assets 86.31b
B: 0.20 (Retained Earnings 17.64b / Total Assets 86.31b)
C: 0.08 (EBIT TTM 6.96b / Avg Total Assets 84.51b)
D: 0.25 (Book Value of Equity 11.49b / Total Liabilities 46.22b)
Altman-Z'' Score: 1.28 = BB
Beneish M -3.19
DSRI: 1.03 (Receivables 5.64b/5.24b, Revenue 34.66b/33.02b)
GMI: 0.80 (GM 45.99% / 36.93%)
AQI: 0.99 (AQ_t 0.52 / AQ_t-1 0.52)
SGI: 1.05 (Revenue 34.66b / 33.02b)
TATA: -0.04 (NI 7.12b - CFO 10.43b) / TA 86.31b)
Beneish M-Score: -3.19 (Cap -4..+1) = AA
What is the price of LIN shares? As of May 21, 2026, the stock is trading at USD 506.63 with a total of 2,048,878 shares traded.
Over the past week, the price has changed by -1.29%, over one month by +1.70%, over three months by +2.38% and over the past year by +11.66%.
Is LIN a buy, sell or hold? Linde Ordinary Shares has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy LIN.
  • StrongBuy: 12
  • Buy: 6
  • Hold: 9
  • Sell: 0
  • StrongSell: 1
What are the forecasts/targets for the LIN price?
Analysts Target Price 541.6 6.9%
Linde Ordinary Shares (LIN) - Fundamental Data Overview as of 18 May 2026
P/E Trailing = 33.5617
P/E Forward = 27.5482
P/S = 6.7522
P/B = 5.9122
P/EG = 2.2959
Revenue TTM = 34.66b USD
EBIT TTM = 6.96b USD
EBITDA TTM = 12.31b USD
Long Term Debt = 19.86b USD (from longTermDebt, last quarter)
Short Term Debt = 4.82b USD (from shortTermDebt, last quarter)
Debt = 24.68b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 20.72b USD (from netDebt column, last quarter)
Enterprise Value = 254.72b USD (234.00b + Debt 24.68b - CCE 3.96b)
Interest Coverage Ratio = 25.42 (Ebit TTM 6.96b / Interest Expense TTM 274.0m)
EV/FCF = 49.98x (Enterprise Value 254.72b / FCF TTM 5.10b)
FCF Yield = 2.00% (FCF TTM 5.10b / Enterprise Value 254.72b)
FCF Margin = 14.70% (FCF TTM 5.10b / Revenue TTM 34.66b)
Net Margin = 20.56% (Net Income TTM 7.12b / Revenue TTM 34.66b)
Gross Margin = 45.99% ((Revenue TTM 34.66b - Cost of Revenue TTM 18.72b) / Revenue TTM)
Gross Margin QoQ = 48.49% (prev 48.12%)
Tobins Q-Ratio = 2.95 (Enterprise Value 254.72b / Total Assets 86.31b)
Interest Expense / Debt = 0.25% (Interest Expense 62.0m / Debt 24.68b)
Taxrate = 23.49% (571.0m / 2.43b)
NOPAT = 5.33b (EBIT 6.96b * (1 - 23.49%))
Current Ratio = 0.83 (Total Current Assets 12.75b / Total Current Liabilities 15.39b)
Debt / Equity = 0.64 (Debt 24.68b / totalStockholderEquity, last quarter 38.57b)
Debt / EBITDA = 1.68 (Net Debt 20.72b / EBITDA 12.31b)
Debt / FCF = 4.07 (Net Debt 20.72b / FCF TTM 5.10b)
Total Stockholder Equity = 38.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.43% (Net Income 7.12b / Total Assets 86.31b)
RoE = 18.51% (Net Income TTM 7.12b / Total Stockholder Equity 38.49b)
RoCE = 11.94% (EBIT 6.96b / Capital Employed (Equity 38.49b + L.T.Debt 19.86b))
RoIC = 8.23% (NOPAT 5.33b / Invested Capital 64.77b)
WACC = 6.41% (E(234.00b)/V(258.68b) * Re(7.07%) + D(24.68b)/V(258.68b) * Rd(0.25%) * (1-Tc(0.23)))
Discount Rate = 7.07% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares (quarterly) Correlation: -100.00 | Cagr: -2.02%
[DCF] Terminal Value 84.40% ; FCFF base≈5.02b ; Y1≈4.92b ; Y5≈5.00b
[DCF] Fair Price = 238.6 (EV 131.04b - Net Debt 20.72b = Equity 110.32b / Shares 462.3m; r=6.41% [WACC]; 5y FCF grow -3.07% → 3.0% )
EPS Correlation: 96.84 | EPS CAGR: 9.32% | SUE: 0.10 | # QB: 0
Revenue Correlation: 40.22 | Revenue CAGR: 1.01% | SUE: 1.18 | # QB: 1
EPS current Quarter (2026-06-30): EPS=4.39 | Chg30d=N/A | Revisions=+60% | Analysts=18
EPS next Quarter (2026-09-30): EPS=4.61 | Chg30d=N/A | Revisions=+0% | Analysts=17
EPS current Year (2026-12-31): EPS=17.95 | Chg30d=N/A | Revisions=+73% | GrowthEPS=+9.0% | GrowthRev=+7.7%
EPS next Year (2027-12-31): EPS=19.71 | Chg30d=N/A | Revisions=+71% | GrowthEPS=+9.8% | GrowthRev=+4.6%
[Analyst] Revisions Ratio: +73%